Barbara Gay Lecture in Child and Adolescent Psychiatry 4/23 | Joan Luby, MD "Early Experience and Brain Development: Informing a New Science of Neurodevelopmental Optimization"
Study to explore treatment for older adults with depression
Older adults with depression face a unique obstacle — dealing with both a mental illness and the challenges that come along with aging. Currently, there are no treatments on the market targeting depression in this specific group.
The Department of Psychiatry and Behavioral Sciences has received a grant to study Sinemet, which may change that. Sinemet, a brand name for the drug levodopa, has historically treated Parkinson’s disease, a brain disorder characterized by injury to dopamine-producing neurons.
Study links ADHD pharmacotherapy and retention rates for substance use disorder treatment
Kristopher Kast, MD, assistant professor in the Department of Psychiatry and Behavioral Sciences and clinical director of Vanderbilt’s Addiction Consult Service, has discovered a strong association between attention-deficit/hyperactivity disorder (ADHD) pharmacotherapy and retention rates for substance use disorder (SUD) treatment.
The findings were reported in the Journal of Clinical Psychiatry.
Amanda Morgan, PhD
Amanda
Morgan
PhD
Research Instructor
Psychiatry and Behavioral Sciences
Aaron Brinen, PsyD
Aaron
Brinen
PsyD
Assistant Professor of Psychiatry and Behavioral Sciences
Division of Psychology
Aaron P. Brinen, PsyD, is a primary developer of recovery-oriented cognitive therapy (CT-R) along with Aaron T. Beck, MD. Under the guidance of Dr. Beck, Dr. Brinen has worked to formalize and standardize the CT-R protocol for individual and group therapy settings, as well as for use in team-based psychiatric care and during inpatient treatment. He is a co-author of the manual of CT-R for serious mental health conditions, and has been active in the training of community therapists from around the world.
Vanderbilt Psychiatric Hospital
1601 23rd Avenue South
Nashville
Tennessee
37212
Dr. Brinen is interested in researching the impact of recovery-oriented cognitive therapy on inpatient and outpatient individuals. Additionally, he is interested in the crossover of different evidence-based treatments, particularly prolonged exposure for PTSD applied to individuals with both PTSD and schizophrenia.
aaron.brinen@vumc.org
Dr. Brinen is a licensed clinical psychologist specializing in cognitive behavioral therapy for individuals with schizophrenia, PTSD, and other disorders.